ArticleScientific reports2025
The dual impact of oxidative stress on breast cancer.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Reactive Oxygen Species in Breast Cancer: From Redox Dysregulation to ROS-Responsive Therapeutics.Cell biochemistry and function · 2026Review
- Breast Cancer and Metabolic Dysfunction-Associated Steatotic Liver Disease.International journal of molecular sciences · 2026Review
- Punicalin Modulates Angiogenesis and Tumor Microenvironment-Related Processes in Triple-Negative Breast Cancer and Endothelial Cells.International journal of molecular sciences · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The impact of oxidative stress on breast cancer remains unknown, and further research is urgently needed. Datasets from TCGA, METABRIC, and GEO were used in this study, and the oxidative stress scores were determined using the least absolute shrinkage and selection operator (LASSO) and Cox regression method. A prognostic model was established using the TCGA-BRCA dataset and verified using the METABRIC and GEO datasets. The microenvironment of breast cancer was evaluated using single-cell data; cell types and oxidative stress scores were evaluated in normal cells, pre-neoplastic cells, and breast cancer cells. An oxidative stress score was calculated with eight genes using LASSO and Cox regression analyses, and a prognostic model with three parameters—age, tumor stage, and oxidative risk score—was established. Good performance was demonstrated by prognostic analysis. Immune cell infiltration indicated that endothelial cells and cancer-associated fibroblasts were higher in the high oxidative stress score group. Single-cell analysis showed that endothelial cells have the lowest degree of differentiation in breast cancer, and was confirmed by pseudo-time analysis. Gene ontology analysis proved that oxidative stress participates in the tumorigenesis and metastasis of breast cancer, which indicate that oxidative stress impact on endothelial cell and participate in tumorigenesis of breast cancer. Interestingly, the oxidative stress score was lower in breast cancer cells because their endothelial cells overexpressed antioxidant-related genes, which allowed breast cancer cells to escape oxidative stress-induced apoptosis. Although oxidative stress is involved in tumorigenesis, it is prevented and eliminated during the promotion and progression stages. Better understanding of tumor microenvironment may facilitate the identification of therapeutic targets and precise treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.